Brussels, 24/10/2000 (Agence Europe) - The European Commission sent a statement of objections to the American company Intercontinental Marketing Services Health (IMS), world leader for the collection of data on prescriptions and sales pharmaceutical products, for abuse of dominant position. Present in certain countries and strong from a turnover of USD 1.4 billion in 1999, IMS offers precious information to pharmaceutical laboratories in order to assess the market share of their medicines...